Page 19 - Quantamental Technologies News Today

Should You Buy or Sell Protagonist Therapeutics Stock? Get The Latest PTGX Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.

Guggenheim upgraded shares of Accolade (NASDAQ:ACCD – Get Rating) from a neutral rating to a buy rating in a report released on Thursday, MarketBeat reports. The brokerage currently has $16.00 price target on the stock. Other research analysts have also issued research reports about the company. Raymond James started coverage on Accolade in a report […]

CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) has received an average recommendation of “Moderate Buy” from the seven research firms that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that […]

StockNews.com upgraded shares of Macerich (NYSE:MAC – Get Rating) from a sell rating to a hold rating in a research report report published on Friday morning. MAC has been the topic of several other research reports. Piper Sandler upped their price target on Macerich from $9.00 to $11.00 and gave the company an underweight rating […]

Clean Energy Fuels Corp. (NASDAQ:CLNE – Get Rating) has received a consensus recommendation of “Moderate Buy” from the eleven analysts that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and six have issued a buy recommendation on the […]

Royal Bank of Canada reaffirmed their sector perform rating on shares of Enanta Pharmaceuticals (NASDAQ:ENTA – Get Rating) in a research report sent to investors on Wednesday morning, Benzinga reports. The firm currently has a $54.00 target price on the biotechnology company’s stock. Several other analysts also recently weighed in on ENTA. Oppenheimer set a […]

AE Wealth Management LLC decreased its holdings in Lucid Group, Inc. (NASDAQ:LCID – Get Rating) by 18.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 14,088 shares of the company’s stock after selling 3,209 shares during the period. AE Wealth […]

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Rating) insider Brian Elsbernd sold 50,000 shares of Catalyst Pharmaceuticals stock in a transaction dated Monday, March 20th. The shares were sold at an average price of $16.07, for a total value of $803,500.00. Following the completion of the sale, the insider now directly owns 138,076 shares in the […]

Shares of Clean Energy Fuels Corp. (NASDAQ:CLNE – Get Rating) have been given an average rating of “Moderate Buy” by the eleven brokerages that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and six have assigned a buy rating to […]

Sonoco Products (NYSE:SON – Get Rating) issued an update on its first quarter earnings guidance on Tuesday morning. The company provided earnings per share guidance of $1.30-1.40 for the period, compared to the consensus earnings per share estimate of $1.17. Sonoco Products Trading Down 0.8 % Shares of SON stock opened at $57.52 on Friday. […]